![DE69938293T2 - LUCIFERASE, GFP FLUORESCENCE PROTEINS, CODING NUCLEIC CAUSE, AND ITS USE IN DIAGNOSIS - Google Patents DE69938293T2 - LUCIFERASE, GFP FLUORESCENCE PROTEINS, CODING NUCLEIC CAUSE, AND ITS USE IN DIAGNOSIS - Google Patents](https://patentimages.storage.googleapis.com/70/28/0a/07ac13fde1c82f/00960001.png)
DE69938293T2 - LUCIFERASE, GFP FLUORESCENCE PROTEINS, CODING NUCLEIC CAUSE, AND ITS USE IN DIAGNOSIS - Google Patents
![EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents](https://patentimages.storage.googleapis.com/f8/01/39/502fb9ab05fe29/imgb0078.png)
EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents
![Initiale Therapie des Typ-2-Diabetes – ein Überblick - Endokrinologie & Diabetologie - Universimed - Medizin im Fokus Initiale Therapie des Typ-2-Diabetes – ein Überblick - Endokrinologie & Diabetologie - Universimed - Medizin im Fokus](https://www.universimed.com/custom/img/files/files_datafiles_data_Zeitungen_2017_Leading%20Opinions_Innere_1706_Weblinks_s15_tab1.jpg)
Initiale Therapie des Typ-2-Diabetes – ein Überblick - Endokrinologie & Diabetologie - Universimed - Medizin im Fokus
![EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents](https://patentimages.storage.googleapis.com/d6/01/30/0a5ea02bb7c62d/imgb0079.png)